ÃÖÀÇ°æ

ÃÖÀÇ°æ

ÃÖÀÇ°æ ±³¼öÀÇ Áø·á½Ã°£Ç¥ Áø·á¿¹¾à

Áø·á°ú/¼¾ÅÍ ¿ù È­ ¼ö ¸ñ ±Ý Åä Àü¹®Áø·á°ú¸ñ
¼Ò¾Æû¼Ò³â°ú
¿ÀÀü
- -
¿ÀÈÄ
- - ½Å»ý¾Æ, ¹Ì¼÷¾Æ, °íÀ§Çè½Å»ý¾Æ, À°¾Æ»ó´ã

ÃÖÀÇ°æ ±³¼öÀÇ »ó¼¼Á¤º¸

ÇзÂ

more
  • 2004 .03 .01 ~  2010 .02 .28 :  °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ ÀÇÇлç
  • 2016 .03 .01 ~  2018 .02 .28 :  ¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ÀÇÇаú ¼®»ç
  • 2018 .03 .01 ~  2022 .02 .28 :  °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ ÀÇÇаú ¹Ú»ç

°æ·Â

more
  • 2010 .03 .01 ~  2015 .02 .28 :  ¼­¿ï´ëÇб³º´¿ø ÀÎÅÏ, ¼Ò¾Æû¼Ò³â°ú ·¹Áö´øÆ®
  • 2016 .03 .01 ~  2017 .02 .28 :  ¼­¿ï´ëÇб³º´¿ø ¼Ò¾Æû¼Ò³â°ú ½Å»ý¾ÆºÐ°ú ÀÓ»ó°­»ç
  • 2017 .03 .01 ~  2018 .02 .28 :  °í´ë¾È»êº´¿ø ¼Ò¾Æû¼Ò³â°ú ½Å»ý¾ÆºÐ°ú ÀÓ»ó°­»ç
  • 2018 .03 .01 ~  2020 .02 .28 :  °í´ë¾È»êº´¿ø ¼Ò¾Æû¼Ò³â°ú ÀÓ»óÁ¶±³¼ö´ë¿ì
  • 2021 .03 .01 ~  2022 .02 .28 :  °í´ë¾È»êº´¿ø ¼Ò¾Æû¼Ò³â°ú ÀÓ»óÁ¶±³¼ö
  • 2022 .03 .01 ~  2022 .08 .31 :  °í´ë±¸·Îº´¿ø ¼Ò¾Æû¼Ò³â°ú ÀÓ»óÁ¶±³¼ö
  • 2022 .09  ~   :  °í´ë±¸·Îº´¿ø ¼Ò¾Æû¼Ò³â°ú Á¶±³¼ö

ÇÐȸȰµ¿

more
  •  ~   :  ´ëÇѼҾÆû¼Ò³â°úÇÐȸ Çб³º¸°Ç ¹× º¸°ÇÅë°èÀ§¿øȸ À§¿ø
  •  ~   :  ´ëÇѼҾÆû¼Ò³â°úÇÐȸ »çȸÇù·Â À§¿ø
  •  ~   :  ´ëÇѸðÀ¯¼öÀ¯ÀÇÇÐȸ º¸ÇèÀÌ»ç
  •  ~   :  ´ëÇѽŻý¾ÆÇÐȸ º¸ÇèÀ§¿øȸ °£»ç
  •  ~   :  ´ëÇÑÁÖ»êÀÇÇÐȸ »ç¹«ÃÑÀå

³í¹®

more
  • [SCI] (Association of delayed initiation of non-invasive respiratory support with pulmonary air leakage in outborn late-preterm and term neonates)
  • [SCI] (Size of Patent Ductus Arteriosus and Echocardiographic Markers of Shunt Volume in Preterm Infants Based on Postnatal Age)
  • [SCI] (Hemodynamics of different volumes of red blood cell transfusion in preterm infants)
  • [SCI] (Perinatal Outcomes Associated with Latency in Late Preterm Premature Rupture of Membranes)
  • [SCI] (Effectiveness of nCPAP for moderate preterm infants compared to BiPAP: A Randomized, Controlled Non-Inferiority Trial)
  • [SCI] (Developmental outcomes of preterm infants with bronchopulmonary dysplasia-associated pulmonary hypertension at 18-24 months of corrected age)

ÃÖÁ¾¼öÁ¤ÀÏ : 2023.01.25